European Association for the Study of the Liver (EASL) Congress 2023
Vienna, Austria 21 June 2023 - 24 June 2023Age, tumour size predict post-TACE complications in HCC patients
21 Jul 2023
bởiStephen Padilla
In patients with hepatocellular carcinoma (HCC), most complications following transarterial chemoembolization (TACE) involve minor postembolization syndrome, reveals a study presented at EASL 2023. The incidence of major complications is high at 25 percent, with a 1.8-percent death rate.
Age, tumour size predict post-TACE complications in HCC patients
21 Jul 2023Phase III data support long-term efficacy of TAF against HBV
18 Jul 2023
bởiAudrey Abella
Two phase III studies presented at EASL 2023 reflected the long-term efficacy of tenofovir alafenamide (TAF) for individuals with HBeAg*-positive and HBeAg-negative chronic hepatitis B virus (HBV).